South Africa Nuclear Imaging Market Size (2024 - 2029)

The market size of nuclear imaging in South Africa is projected to experience growth over the forecast period, driven by advancements in medical imaging technology and the increasing adoption of nuclear imaging equipment. Despite challenges posed by the COVID-19 pandemic, which affected clinical services and supply chains, the market has seen opportunities for expansion. The country's existing infrastructure for radioisotope production has mitigated some supply issues, while the demand for nuclear imaging in diagnosing cancer and cardiac diseases continues to rise. This growth trajectory is supported by investments and the establishment of direct market operations by key industry players, contributing to the overall economic development of South Africa.

Market Size of South Africa Nuclear Imaging Industry

CAGR
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 67.45 Million
Market Size (2029) USD 77.30 Million
CAGR (2024 - 2029) 2.76 %
Market Concentration Medium

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

South Africa Nuclear Imaging Market Analysis

The South Africa Nuclear Imaging Market size is estimated at USD 67.45 million in 2024, and is expected to reach USD 77.30 million by 2029, growing at a CAGR of 2.76% during the forecast period (2024-2029).

According to a study titled 'Nuclear Medicine Operations in the Times of COVID-19: Strategies, Precautions, and Experiences' published in the Journal of Nuclear Medicine in May 2020, the nuclear medicine staff in the country have been instructed to have refresher courses on infection control management and basic emergency management. South Africa saw a reduction in the clinical service for nonurgent scans, and inpatient and urgent outpatient studies, especially in oncology. The country had an inbuilt supply of many radioisotopes, as the country has nuclear reactors from Jubilant Pharmova and therefore was not affected by shortages of radiopharmaceuticals, but the country was dependent on overseas supply for many kits and reagents and the shutdown of airline flights have caused shortages for those kits and reagents.

However, COVID-19 has opened many opportunities for the market players in the industry to identify and tap the market and expand their operations to generate revenue for their company. For instance, In 2020, Jubliant Pharmova, one of the provoders of radiopharmaceuticals, started its own office in South Africa as part of its long-term plan of going direct to market with its own sales team. This will bring investment in the South African economy thus improving the country's economic condition.

Nuclear imaging is hugely capable of diagnosing cancer and cardiac diseases. Nuclear medicine scans ( also known as nuclear imaging, radionuclide imaging, and nuclear scans) can help doctors find tumors and see how much cancer has spread in the body. Cardiac nuclear medicine imaging evaluates the heart for coronary artery disease and cardiomyopathy (diseases of the heart muscle). It also may be used to help determine whether the heart has been damaged by chemotherapy or radiotherapy. Additionally, as per the 2021 data from International Society for Optics and Photonics, South Africa is rapidly acquiring high-tech medical imaging equipment such as multi-slice helical computed tomography (CT) scanners, as well as hybrid imaging technologies like combining single photon emission computed tomography and positron emission tomography with CT. This adoption of nuclear imaging equipment is expected to boost the market growth in South Africa over the forecast period.

South Africa Nuclear Imaging Industry Segmentation

As per the scope of this report, Nuclear medicine imaging procedures are non-invasive, with the exception of intravenous injections, and are usually painless medical tests that help physicians diagnose and evaluate medical conditions. These imaging scans use radioactive materials called radiopharmaceuticals or radiotracers. These radiopharmaceuticals are used in diagnosis and therapeutics. South Africa Nuclear Imaging Market is segmented by Product (Equipment, Diagnostic Radioisotopes), and Application (SPECT Applications, PET Applications). The report offers the value (in USD million) for the above segments. 

By Product
Equipment
Diagnostic Radioisotope
SPECT Radioisotopes
PET Radioisotopes
By Application
SPECT Applications
Cardiology
Neurology
Thyroid
Other SPECT Applications
PET Applications
Oncology
Cardiology
Neurology
Other PET Applications
Need A Different Region Or Segment?
Customize Now

South Africa Nuclear Imaging Market Size Summary

The nuclear imaging market in South Africa is poised for growth, driven by advancements in medical technology and strategic industry developments. The market is characterized by the increasing adoption of high-tech medical imaging equipment, such as multi-slice helical CT scanners and hybrid imaging technologies, which are enhancing diagnostic capabilities for cancer and cardiac diseases. The country's robust infrastructure, including nuclear reactors and a strong supply of radioisotopes, supports the market's expansion. Despite challenges posed by the COVID-19 pandemic, such as shortages in overseas supplies, the industry has seen opportunities for growth, with companies like Jubilant Pharmova establishing a direct market presence in South Africa. This strategic move is expected to bolster the local economy and enhance the availability of radiopharmaceuticals.

The competitive landscape of the South African nuclear imaging market is dominated by major players such as Bracco Imaging SpA, Curium, Cardinal Health Inc., Koninklijke Philips NV, GE Healthcare, and Siemens Healthineers. These companies hold significant market shares and are actively involved in partnerships and collaborations to expand their reach and capabilities. Notable collaborations include agreements for the commercialization of advanced imaging products and the establishment of cyclotron-based radiopharmacy businesses. Additionally, South Africa's position as a leading producer of medical nuclear isotopes and its international collaborations in nuclear medicine research further contribute to the market's growth prospects. As the demand for advanced diagnostic tools continues to rise, the nuclear imaging market in South Africa is expected to experience sustained expansion over the forecast period.

Explore More

South Africa Nuclear Imaging Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Prevalence of Cancer and Cardiac Disorders

      2. 1.2.2 Technological Advancements in Nuclear Imaging

    3. 1.3 Market Restraints

      1. 1.3.1 Stringent Regulations

    4. 1.4 Porter's Five Forces Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD million)

    1. 2.1 By Product

      1. 2.1.1 Equipment

      2. 2.1.2 Diagnostic Radioisotope

        1. 2.1.2.1 SPECT Radioisotopes

        2. 2.1.2.2 PET Radioisotopes

    2. 2.2 By Application

      1. 2.2.1 SPECT Applications

        1. 2.2.1.1 Cardiology

        2. 2.2.1.2 Neurology

        3. 2.2.1.3 Thyroid

        4. 2.2.1.4 Other SPECT Applications

      2. 2.2.2 PET Applications

        1. 2.2.2.1 Oncology

        2. 2.2.2.2 Cardiology

        3. 2.2.2.3 Neurology

        4. 2.2.2.4 Other PET Applications

South Africa Nuclear Imaging Market Size FAQs

The South Africa Nuclear Imaging Market size is expected to reach USD 67.45 million in 2024 and grow at a CAGR of 2.76% to reach USD 77.30 million by 2029.

In 2024, the South Africa Nuclear Imaging Market size is expected to reach USD 67.45 million.

Nuclear Imaging Market in South Africa Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)